                         SEQUENCE LISTING

<110>  ARTIFICIAL CELL TECHNOLOGIES, INC.
       POWELL, THOMAS J.
 
<120>  ANTI-MALARIA COMPOSITIONS AND METHODS

<130>  ATE0042US2

<150>  62/741,198
<151>  2018-10-04

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  397
<212>  PRT
<213>  Plasmodium falciparum

<400>  1

Met Met Arg Lys Leu Ala Ile Leu Ser Val Ser Ser Phe Leu Phe Val 
1               5                   10                  15      


Glu Ala Leu Phe Gln Glu Tyr Gln Cys Tyr Gly Ser Ser Ser Asn Thr 
            20                  25                  30          


Arg Val Leu Asn Glu Leu Asn Tyr Asp Asn Ala Gly Thr Asn Leu Tyr 
        35                  40                  45              


Asn Glu Leu Glu Met Asn Tyr Tyr Gly Lys Gln Glu Asn Trp Tyr Ser 
    50                  55                  60                  


Leu Lys Lys Asn Ser Arg Ser Leu Gly Glu Asn Asp Asp Gly Asn Asn 
65                  70                  75                  80  


Glu Asp Asn Glu Lys Leu Arg Lys Pro Lys His Lys Lys Leu Lys Gln 
                85                  90                  95      


Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
            100                 105                 110         


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
        115                 120                 125             


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
    130                 135                 140                 


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
145                 150                 155                 160 


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
                165                 170                 175     


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
            180                 185                 190         


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Ala Asn Pro 
        195                 200                 205             


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
    210                 215                 220                 


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
225                 230                 235                 240 


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
                245                 250                 255     


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro 
            260                 265                 270         


Asn Lys Asn Asn Gln Gly Asn Gly Gln Gly His Asn Met Pro Asn Asp 
        275                 280                 285             


Pro Asn Arg Asn Val Asp Glu Asn Ala Asn Ala Asn Ser Ala Val Lys 
    290                 295                 300                 


Asn Asn Asn Asn Glu Glu Pro Ser Asp Lys His Ile Lys Glu Tyr Leu 
305                 310                 315                 320 


Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Cys Ser Val 
                325                 330                 335     


Thr Cys Gly Asn Gly Ile Gln Val Arg Ile Lys Pro Gly Ser Ala Asn 
            340                 345                 350         


Lys Pro Lys Asp Glu Leu Asp Tyr Ala Asn Asp Ile Glu Lys Lys Ile 
        355                 360                 365             


Cys Lys Met Glu Lys Cys Ser Ser Val Phe Asn Val Val Asn Ser Ser 
    370                 375                 380                 


Ile Gly Leu Ile Met Val Leu Ser Phe Leu Phe Leu Asn 
385                 390                 395         


<210>  2
<211>  16
<212>  PRT
<213>  plasmodium falciparum

<400>  2

Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val 
1               5                   10                  15      


<210>  3
<211>  4
<212>  PRT
<213>  plasmodium falciparum

<400>  3

Asn Ala Asn Pro 
1               


<210>  4
<211>  20
<212>  PRT
<213>  plasmodium falciparum

<400>  4

Glu Tyr Leu Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro 
1               5                   10                  15      


Cys Ser Val Thr 
            20  


<210>  5
<211>  20
<212>  PRT
<213>  artificial

<220>
<223>  modified t* epitope

<400>  5

Glu Tyr Leu Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro 
1               5                   10                  15      


Ser Ser Val Thr 
            20  


<210>  6
<211>  15
<212>  PRT
<213>  plasmodium falciparum

<400>  6

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Ser 
1               5                   10                  15  


<210>  7
<211>  91
<212>  PRT
<213>  artificial

<220>
<223>  Designed peptide T1BT*M

<400>  7

Asp Glu Ser Ile Gly Asn Glu Asp Pro Glu Pro Thr Ile Asp Glu Thr 
1               5                   10                  15      


Asx Thr Met Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn 
            20                  25                  30          


Pro Asn Val Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu 
        35                  40                  45              


Tyr Leu Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Ser 
    50                  55                  60                  


Ser Val Thr Ser Gly Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70                  75                  80  


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
                85                  90      


<210>  8
<211>  72
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide T1BT*

<400>  8

Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val 
1               5                   10                  15      


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu Tyr Leu Asn 
            20                  25                  30          


Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Cys Ser Val Thr 
        35                  40                  45              


Ser Gly Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60                  


Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70          


<210>  9
<211>  72
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide T*M

<400>  9

Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val 
1               5                   10                  15      


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu Tyr Leu Asn 
            20                  25                  30          


Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Ser Ser Val Thr 
        35                  40                  45              


Ser Gly Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60                  


Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70          


<210>  10
<211>  72
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide T*

<400>  10

Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val 
1               5                   10                  15      


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu Tyr Leu Asn 
            20                  25                  30          


Lys Ile Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Cys Ser Val Thr 
        35                  40                  45              


Ser Gly Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60                  


Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70          


<210>  11
<211>  48
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide T1B

<400>  11

Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val 
1               5                   10                  15      


Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Lys Lys Lys Lys 
            20                  25                  30          


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
        35                  40                  45              


<210>  12
<211>  39
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  peptide CIS43

<400>  12

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
            20                  25                  30          


Lys Lys Lys Lys Lys Lys Lys 
        35                  


<210>  13
<211>  86
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T1BT*M

<400>  13

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val Asn Ala 
            20                  25                  30          


Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu Tyr Leu Asn Lys Ile 
        35                  40                  45              


Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Ser Ser Val Thr Ser Gly 
    50                  55                  60                  


Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70                  75                  80  


Lys Lys Lys Lys Lys Lys 
                85      


<210>  14
<211>  86
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T1BT*

<400>  14

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val Asn Ala 
            20                  25                  30          


Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Glu Tyr Leu Asn Lys Ile 
        35                  40                  45              


Gln Asn Ser Leu Ser Thr Glu Trp Ser Pro Cys Ser Val Thr Ser Gly 
    50                  55                  60                  


Asn Gly Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
65                  70                  75                  80  


Lys Lys Lys Lys Lys Lys 
                85      


<210>  15
<211>  62
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T1B

<400>  15

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val Asn Ala 
            20                  25                  30          


Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Lys Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60          


<210>  16
<211>  62
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T1

<400>  16

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn Pro Asn Val Asn Ala 
            20                  25                  30          


Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Lys Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60          


<210>  17
<211>  51
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43B

<400>  17

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Lys 
            20                  25                  30          


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Lys Lys 
    50      


<210>  18
<211>  63
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T*M

<400>  18

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Glu Tyr Leu Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu 
            20                  25                  30          


Trp Ser Pro Ser Ser Val Thr Ser Gly Asn Gly Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60              


<210>  19
<211>  63
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  Designed peptide CIS43T*

<400>  19

Pro Ala Asp Gly Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro 
1               5                   10                  15      


Asn Ala Asn Glu Tyr Leu Asn Lys Ile Gln Asn Ser Leu Ser Thr Glu 
            20                  25                  30          


Trp Ser Pro Cys Ser Val Thr Ser Gly Asn Gly Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
    50                  55                  60              


<210>  20
<211>  15
<212>  PRT
<213>  plasmodium falciparum

<400>  20

Asn Pro Asp Pro Asn Ala Asn Pro Asn Val Asp Pro Asn Ala Asn 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  plasmodium falciparum

<400>  21

Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn Pro Asn Ala Asn 
1               5                   10                  15  


